Drugs / TK-8001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05430555 | Jul 2022 → Jan 2024 | cancer | T-knife GmbH | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TK-8001 | “clinical trial of TK-8001 (MAGE-A1-Directed TCR-Transduced Autologous CD8+ T-cells)” NCT05430555 ↗ |